Healthy Living

University of Southern California Announces Hodgkin's Lymphoma Breakthrough

The researchers also learned more about lymphoma itself

Pei Chuan Li is the lead author of the study, as well as a postdoctoral fellow within Shih's lab. He explained their results, "combining MAO-A inhibitors with current treatment was more effective than each treatment alone."

In this study, the researchers also discovered that analyzing MAO-A in Hodgkin's lymphoma may actually offer information into the biology of the lymphoma itself. By obtaining this information, researchers will have further access into how lymphomas vary - enabling more precise diagnosis that may aid patients who previously showed "grey area" symptoms, which means that their condition was hard to differentiate from other forms of lymphoma.